Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 110

    1.

    Gene therapy for retinopathy of prematurity: the eye is a window to the future.

    Good WV, Gendron RL.

    Br J Ophthalmol. 2001 Aug;85(8):891-2. No abstract available. PMID: 11466236 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity.

    Chowers I, Banin E, Hemo Y, Porat R, Falk H, Keshet E, Pe'er J, Panet A.

    Br J Ophthalmol. 2001 Aug;85(8):991-5.PMID: 11466260 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer.

    Rota R, Riccioni T, Zaccarini M, Lamartina S, Gallo AD, Fusco A, Kovesdi I, Balestrazzi E, Abeni DC, Ali RR, Capogrossi MC.

    J Gene Med. 2004 Sep;6(9):992-1002.PMID: 15352072 [PubMed - indexed for MEDLINE]Related articles

    4.

    Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies.

    Holmström G, van Wijngaarden P, Coster DJ, Williams KA.

    Br J Ophthalmol. 2007 Dec;91(12):1704-8. Review.PMID: 18024814 [PubMed - indexed for MEDLINE]Related articles

    5.

    Genomics and proteomics of retinopathy of prematurity: DNA-based prevention and treatment.

    Good WV, Gendron RL.

    Br J Ophthalmol. 2007 Dec;91(12):1577. No abstract available. PMID: 18024806 [PubMed - indexed for MEDLINE]Related articles

    6.

    Retinopathy of prematurity: molecular pathology and therapeutic strategies.

    Mechoulam H, Pierce EA.

    Am J Pharmacogenomics. 2003;3(4):261-77. Review.PMID: 12930159 [PubMed - indexed for MEDLINE]Related articles

    7.

    Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat.

    van Wijngaarden P, Brereton HM, Gibbins IL, Coster DJ, Williams KA.

    Exp Eye Res. 2007 Oct;85(4):508-17. Epub 2007 Jul 10.PMID: 17692314 [PubMed - indexed for MEDLINE]Related articles

    8.

    Differences between rat strains in models of retinopathy of prematurity.

    Floyd BN, Leske DA, Wren SM, Mookadam M, Fautsch MP, Holmes JM.

    Mol Vis. 2005 Jul 19;11:524-30.PMID: 16052168 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Anti-vascular endothelial growth factor and retinopathy of prematurity.

    Sears JE.

    Br J Ophthalmol. 2008 Nov;92(11):1437-8. No abstract available. PMID: 18952651 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Direct measurement of retinal oxygen tension in experimental retinopathy of prematurity (author's transl)]

    Yamagishi N, Tsuruoka Y, Okuda T, Nagata M.

    Nippon Ganka Gakkai Zasshi. 1977 Sep 10;81(9):1500-8. Japanese. No abstract available. PMID: 580161 [PubMed - indexed for MEDLINE]Related articles

    11.

    The relationship of retinal VEGF and retinal IGF-1 mRNA with neovascularization in an acidosis-induced model of retinopathy of prematurity.

    Leske DA, Wu J, Mookadam M, Chen Y, Fautsch MP, Holmes JM, Lanier WL.

    Curr Eye Res. 2006 Feb;31(2):163-9.PMID: 16500767 [PubMed - indexed for MEDLINE]Related articles

    12.

    Genetic influences on susceptibility to oxygen-induced retinopathy.

    van Wijngaarden P, Brereton HM, Coster DJ, Williams KA.

    Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1761-6.PMID: 17389509 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity.

    Bányász I, Bokodi G, Vannay A, Szebeni B, Treszl A, Vásárhelyi B, Tulassay T, Szabó A.

    Curr Eye Res. 2006 Jul-Aug;31(7-8):685-90.PMID: 16877277 [PubMed - indexed for MEDLINE]Related articles

    14.

    Genetic susceptibility to retinopathy of prematurity.

    Bizzarro MJ, Hussain N, Jonsson B, Feng R, Ment LR, Gruen JR, Zhang H, Bhandari V.

    Pediatrics. 2006 Nov;118(5):1858-63.PMID: 17079555 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin.

    Morita M, Ohneda O, Yamashita T, Takahashi S, Suzuki N, Nakajima O, Kawauchi S, Ema M, Shibahara S, Udono T, Tomita K, Tamai M, Sogawa K, Yamamoto M, Fujii-Kuriyama Y.

    EMBO J. 2003 Mar 3;22(5):1134-46.PMID: 12606578 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Gene therapy for ocular neovascularization: a cure in sight.

    Reich SJ, Bennett J.

    Curr Opin Genet Dev. 2003 Jun;13(3):317-22.PMID: 12787796 [PubMed - indexed for MEDLINE]Related articles

    17.

    Inhibition of vascular endothelial growth factor-induced retinal neovascularization by retinoic acid in experimental retinopathy of prematurity.

    Ozkan H, Duman N, Kumral A, Kasap B, Ozer EA, Lebe B, Yaman A, Berk T, Yilmaz O, Ozer E.

    Physiol Res. 2006;55(3):267-75. Epub 2005 Aug 5.PMID: 16083310 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.

    McCollum GW, Rajaratnam VS, Bullard LE, Yang R, Penn JS.

    Exp Eye Res. 2004 May;78(5):987-95.PMID: 15051479 [PubMed - indexed for MEDLINE]Related articles

    19.

    SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.

    Wilkinson-Berka JL, Jones D, Taylor G, Jaworski K, Kelly DJ, Ludbrook SB, Willette RN, Kumar S, Gilbert RE.

    Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1600-5.PMID: 16565398 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Therapy for retinopathy of prematurity.

    Fleck BW.

    Lancet. 1999 Jan 16;353(9148):166-7. No abstract available. PMID: 9923868 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data